Harvard Combined Orthopaedic Residency Program, Harvard Medical School.
Department of Orthopaedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Clin Spine Surg. 2023 Aug 1;36(7):E317-E323. doi: 10.1097/BSD.0000000000001371. Epub 2022 Aug 9.
This was a retrospective cohort study.
To characterize the variability in cost for anterior cervical discectomy and fusion (ACDF) constructs and to identify key predictors of procedural cost.
ACDF is commonly performed for surgical treatment of cervical radiculopathy and myelopathy. Numerous biomechanical constructs and graft/biological options are available, with most demonstrating relatively equivalent clinical results. Despite the substantial focus on value in spine care, the differences and contributions to procedural cost in ACDF have not been well defined.
We evaluated the records of patients who underwent a single level ACDF from 2016 to 2020 at 4 hospitals in a major metropolitan area. We abstracted demographics, insurance status, operative time, diagnosis, surgeon, institution, and components of procedural costs. Costs based on construct were compared using multivariable adjusted analyses using negative binomial regression. The primary outcome measures were cost differences between ACDF techniques.
Two hundred sixty-four patients were included, with procedures by 13 surgeons across 4 institutions. The total procedural cost for ACDF had a mean of US$2317 with wide variation (range, US$967-US$7370). Multivariable analysis revealed body mass index and use of polyether ether ketone to be correlated with increased cost while carbon fiber and autograft correlated with decreased cost. When comparing standalone device constructs to cases with anterior instrumentation (plate/screws), the total cost was significantly higher in the plate/screw group (US$2686±US$921 vs. US$1466±US$878, P <0.001).
We encountered wide variation in procedural costs associated with ACDF, including as much as an 8-fold difference in the cost of constructs. The most important drivers included instrumentation type and implant materials. Here, we identify potential targets of opportunity for health care organizations that are looking to reduce variance in procedural expenditures to improve health care savings associated with the performance of ACDF.
这是一项回顾性队列研究。
描述颈椎前路椎间盘切除融合术(ACDF)构建物成本的变异性,并确定手术成本的关键预测因素。
ACDF 常用于治疗颈椎神经根病和颈椎病的手术治疗。有许多生物力学构建物和移植物/生物选项可供选择,大多数都显示出相对等效的临床结果。尽管在脊柱护理方面非常重视价值,但 ACDF 中手术成本的差异及其对手术成本的贡献尚未得到很好的定义。
我们评估了 2016 年至 2020 年在一个主要大都市区的 4 家医院接受单节段 ACDF 的患者的记录。我们提取了人口统计学、保险状况、手术时间、诊断、外科医生、机构以及手术成本构成的信息。使用多变量调整分析,使用负二项回归比较基于构建物的成本差异。主要的观察结果是 ACDF 技术之间的成本差异。
共有 264 名患者入组,由 4 家医院的 13 名外科医生进行了手术。ACDF 的总手术成本平均值为 2317 美元,但差异很大(范围为 967 美元至 7370 美元)。多变量分析显示,体重指数和使用聚醚醚酮与成本增加相关,而碳纤维和自体移植物与成本降低相关。当比较独立的器械构建物与具有前路器械(钢板/螺钉)的病例时,钢板/螺钉组的总费用明显更高(2686±921 美元 vs. 1466±878 美元,P<0.001)。
我们发现 ACDF 相关手术成本存在广泛差异,包括构建物成本差异高达 8 倍。最重要的驱动因素包括器械类型和植入物材料。在这里,我们确定了医疗保健组织有机会降低手术支出的差异,以提高与 ACDF 相关的医疗保健储蓄。